Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia. Fujieda S, Wang C, Yoshikawa M, Asako M, et al. Rhinology 2024;62:576-589.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fujieda S, Wang C, Yoshikawa M, Asako M, et al. Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia. Rhinology 2024;62:576-589.
PMID: 39058315